SignatureFD’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-12
| Closed | -$8 | – | 3289 |
|
|
2023
Q4 | $8 | Hold |
12
| – | – | ﹤0.01% | 3116 |
|
|
2023
Q3 | $8 | Hold |
12
| – | – | ﹤0.01% | 3185 |
|
|
2023
Q2 | $29 | Hold |
12
| – | – | ﹤0.01% | 3204 |
|
|
2023
Q1 | $100 | Hold |
12
| – | – | ﹤0.01% | 3239 |
|
|
2022
Q4 | $146 | Hold |
12
| – | – | ﹤0.01% | 3210 |
|
|
2022
Q3 | $0 | Hold |
12
| – | – | ﹤0.01% | 3412 |
|
|
2022
Q2 | $0 | Hold |
12
| – | – | ﹤0.01% | 3400 |
|
|
2022
Q1 | $0 | Hold |
12
| – | – | ﹤0.01% | 3368 |
|
|
2021
Q4 | $1K | Hold |
12
| – | – | ﹤0.01% | 3043 |
|
|
2021
Q3 | $1K | Hold |
12
| – | – | ﹤0.01% | 2973 |
|
|
2021
Q2 | $1K | Hold |
12
| – | – | ﹤0.01% | 2889 |
|
|
2021
Q1 | $1K | Hold |
12
| – | – | ﹤0.01% | 2717 |
|
|
2020
Q4 | $0 | Buy |
+12
| New | +$534 | ﹤0.01% | 2743 |
|
|
2020
Q3 | – | Sell |
-12
| Closed | – | – | 2794 |
|
|
2020
Q2 | $0 | Hold |
12
| – | – | ﹤0.01% | 2708 |
|
|
2020
Q1 | $0 | Hold |
12
| – | – | ﹤0.01% | 2509 |
|
|
2019
Q4 | $1K | Hold |
12
| – | – | ﹤0.01% | 2142 |
|
|
2019
Q3 | $1K | Hold |
12
| – | – | ﹤0.01% | 2041 |
|
|
2019
Q2 | $1K | Hold |
12
| – | – | ﹤0.01% | 1979 |
|
|
2019
Q1 | $2K | Hold |
12
| – | – | ﹤0.01% | 1812 |
|
|
2018
Q4 | $2K | Hold |
12
| – | – | ﹤0.01% | 1764 |
|
|
2018
Q3 | $3K | Hold |
12
| – | – | ﹤0.01% | 1660 |
|
|
2018
Q2 | $3K | Hold |
12
| – | – | ﹤0.01% | 1682 |
|
|
2018
Q1 | $3K | Buy |
+12
| New | +$3.15K | ﹤0.01% | 1524 |
|
|
2016
Q4 | – | Sell |
-12
| Closed | -$3K | – | 1307 |
|
|
2016
Q3 | $3K | Hold |
12
| – | – | ﹤0.01% | 1376 |
|
|
2016
Q2 | $2K | Buy |
+12
| New | +$5.53K | ﹤0.01% | 1266 |
|
Other funds holding DMK
SignatureFD's DMK Position: Q1 2024 in Review
SignatureFD sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 12 shares — an estimated $8 sold.
SignatureFD first reported a position in DMK in Q2 2016 and held it in 25 quarters. The position peaked at $3K in Q3 2018. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.
- SignatureFD reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
- SignatureFD sold 12 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $8.
- SignatureFD first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2016 and held it in 25 quarters.
- SignatureFD's DMK Pharmaceuticals Corporation Common Stock position peaked at $3K in Q3 2018.
- 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.
Based on SignatureFD's 13F filing for Q1 2024, filed 3 May 2024.